3-D Virtual Reality Colonoscopy
Using advanced 3-D imaging technology, Judy Yee is reinventing the colonoscopy process.
University of California San Francisco
Give to UCSFUsing advanced 3-D imaging technology, Judy Yee is reinventing the colonoscopy process.
With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance.
The UCSF community is deeply saddened by the passing of Andrew S. Grove, former CEO and chairman of Intel Corp., who applied his drive for innovation to advocacy for advancements in health care and the treatment of cancer and Parkinson’s disease.
Finding the right dose for each patient is complex, and incorrect dosing can have major consequences. Researchers in the UCSF School of Pharmacy are finding new ways to harness the power of big data, building effective dosing models that allow for precisely individualized medicine.
If depression is caused by flawed brain circuitry, it may be possible to shift that circuitry toward healthy neural processing instead. UCSF researchers hope to map and correct aberrant neural behavior to cure mood disorders.
UCSF and Cisco have formed an initiative to jointly develop an interoperability platform for sharing health care information among multiple entities.
Did you miss UC San Francisco at Dreamforce 2015? Watch some of the featured presentations.
Building on the success of the Health eHeart Study at UCSF, the National Institutes of Health has awarded $9.75 million to UCSF over the next five years for creation of Health ePeople.
A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN), a consortium comprising research groups from UCSF, the University of Chicago and the University of Toronto, will support the development of next-generation, antibody-based cancer therapies.
UCSF is partnering with the Salesforce Foundation to support Dreamforce 2015, where experts will explore ways to improve healthcare and research.
Two demonstration projects that aim to yield quick results for patients have been selected by the new California Initiative to Advance Precision Medicine, a public-private effort launched by Governor Edmund G. Brown Jr.
Brains age, just like the rest of the body, even for those don't get neurological disease, according to an Institute of Medicine report released on April 14. While aging does more damage to some than others, most people can take steps to improve their health.
UCSF Magazine explores how scientists are uncovering surprising new tools – young blood and video games – to rejuvenate the brain.
UCSF’s Institute for Global Orthopaedics and Traumatology allows residents to do an international rotation to train doctors in the developing world, where traffic accidents are one of the most common causes of hospitalization.
Drugs made from naturally occurring molecules found in fish oil could help thousands of Americans whose coronary and leg arteries renarrow after surgery.
UCSF has unveiled a new cloud-based software platform that significantly advances precision medicine for cancer.
Researchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases.
Video games that make you smarter. A chip that can identify mysterious illnesses in hours. These are some of the topics top UCSF scientists will discuss at this year’s free UCSF Dreamforce track on Oct. 15.
An unprecedented, public-private partnership funded by the Department of Defense is being launched to drive the development of better-run clinical trials and may lead to the first successful treatments for traumatic brain injury.
Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
The ALS Treatment and Research Center, a clinical practice of the Department of Neurology at UCSF and an ALS Association-certified Center of Excellence, is expanding its support for the community of people facing amyotrophic lateral sclerosis.
Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
UCSF and Walgreens have opened a unique Walgreens store that aims to improve medication safety, decrease health care costs and help patients use medicines more effectively.
Geneticists from Ohio, California and Japan used stem cells to correct a defective “ring chromosome” with a normal chromosome. Such therapy has the promise to correct chromosome abnormalities that give rise to birth defects, mental disabilities and growth limitations.
UCSF and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine.
The nation’s top scientists will gather at UCSF to discuss the latest in research discovery at a special symposium honoring the 2013 and 2014 Breakthrough Prize in Life Sciences Award recipients on Friday, Dec. 13.
Carlin Senter, MD, leader of UCSF’s concussion program, answers some frequently asked questions about this common brain injury.
Top thinkers gather at UCSF to help make the new field a reality.
Precision Medicine Pillar No. 5: Omics Medicine. Molecular biologist Nevan Krogan's work is not only illuminating how genes and proteins function, it's also shedding light on the underlying biology of disease for each person.
Precision Medicine Pillar No. 6: Digital Health. The Center for Digital Health Innovation shepherds the development of digital health innovations created at UCSF and validates the effectiveness of devices from both inside and outside the institution.